Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis
Despite all the medical advances mortality due to cirrhosis and hepatocellular carcinoma, the end stages of fibrosis, continuously increases. Recent data suggest that liver fibrosis is guided by type 3 inflammation with IL-17A at the top of the line. The storage of vitamin A and its active metabolit...
Main Authors: | Daria M. Kartasheva-Ebertz, Stanislas Pol, Sylvie Lagaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.691073/full |
Similar Items
-
Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A
by: Lixi Li, et al.
Published: (2020-01-01) -
Clonorchis sinensis lysophospholipase A upregulates IL-25 expression in macrophages as a potential pathway to liver fibrosis
by: Lina Zhou, et al.
Published: (2017-06-01) -
Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways
by: Cheng-Hao Weng, et al.
Published: (2020-03-01) -
The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01) -
Anthocyanin Protects Cardiac Function and Cardiac Fibroblasts From High-Glucose Induced Inflammation and Myocardial Fibrosis by Inhibiting IL-17
by: Er Yue, et al.
Published: (2021-02-01)